About the Cancer Neoantigens Session
Cancer neoantigens are novel peptides presented by cancer cells that arise from tumor-specific mutations. Unlike normal cellular proteins, these neoantigens are recognized as foreign by the immune system, making them promising targets for cancer immunotherapy. Neoantigen-based therapies, such as personalized cancer vaccines and adoptive T-cell transfer, aim to harness the body’s immune response to selectively attack tumor cells while sparing healthy tissue. Recent advances in genomics and bioinformatics have accelerated the identification and validation of neoantigens, paving the way for highly individualized treatments. These therapies hold potential for improved efficacy and reduced toxicity compared to traditional cancer treatments, marking a significant advancement in personalized oncology.
Topics Covered in Cancer Neoantigens
Neoantigen Prediction
HLA Antigen Presentation
Personalized Vaccines
Adoptive T-Cell Therapy
Tumor Mutational Burden
Frameshift & Fusion Antigens
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Neoantigens Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Neoantigens work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Neoantigens research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Neoantigens track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Neoantigens Conference 2027 — FAQs
What is the Cancer Neoantigens track at CIOC 2027?
The Cancer Neoantigens track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Neoantigens. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Neoantigens sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Neoantigens are all welcome — whether presenting or attending.
Can I present my research in the Cancer Neoantigens track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Neoantigens sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Neoantigens track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.